Artificial Intelligence in Drug Discovery Podcast
1) Nick Lynch of the Pistoia Alliance on AI as a Strategic Focus
On this episode, I speak with Nick Lynch of the Pistoia Alliance ( www.pistoiaalliance.org ), a global nonprofit community of life science stakeholders that works to lower barriers to R&D innovation. ...Show More
2) Lucas Siow of ProteinQure on AI for Protein-Based Drugs
On this episode, I speak with Lucas Siow, Head of Business Operations at ProteinQure ( www.proteinqure.com ). ProteinQure uses artificial intelligence and quantum computing to design protein-based dru...Show More
3) Regina Barzilay, AI Small Molecule Discovery and Synthesis
On this episode, I speak with Regina Barzilay of MIT's Machine Learning for Pharmaceutical Discovery and Synthesis consortium ( http://mlpds.mit.edu ). Regina is a prolific researcher with many highly...Show More
4) Tim Guilliams and David Brown, Healx, AI for Rare Diseases
On this episode, I speak with Tim Guilliams and David Brown of Healx. Healx uses AI to repurpose existing drugs for rare diseases. They claim their approach can bring new treatments to patients 80% fa...Show More
5) John Cassidy, CEO, Cambridge Cancer Genomics, AI in Oncology
On this episode, I speak with John Cassidy, CEO of Cambridge Cancer Genomics ( www.ccg.ai ). CCG aims to transform oncology by combining liquid biopsy with genomics and artificial intelligence to pred...Show More
6) Kristen Fortney, CEO of BioAge Labs, on AI Aging Research
On this episode, I speak with Kristen Fortney, founder and CEO of BioAge Labs ( www.bioagelabs.com ). Kristen leads one of just a few companies focused explicitly on aging itself, rather than the dise...Show More
7) Sam Cooper, CEO of Phenomic AI, on Automated HCS and More
On this episode, I speak with Sam Cooper, cofounder and CEO of Phenomic AI ( www.phenomic.ai ). Sam and his team use machine learning for automated image analysis to study cell biology and screen drug...Show More
8) Shai Shen-Orr, Chief Scientist, CytoReason, AI in Immunology
On this episode, I speak with Shai Shen-Orr, cofounder and chief scientist of CytoReason ( www.cytoreason.com ). CytoReason has created a machine learning model of the immune system. This model can in...Show More
9) Leila Pirhaji, CEO of ReviveMed, on AI for Metabolomics
On this episode, I speak with Leila Pirhaji, founder and CEO of ReviveMed ( www.revive-med.com ). ReviveMed uses artificial intelligence to unlock the therapeutic potential of metabolomics. Before lea...Show More
10) Mostapha Benhenda of Startcrowd on AI Drug Discovery Hype
On this episode, I speak with Mostapha Benhenda of Startcrowd ( http://www.startcrowd.club ). In January, Mostapha wrote a controversial article critiquing several research labs ( https://bit.ly/2qINv...Show More